Clinical Trial

Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses.

Study acronym: SEARCH-1
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the diagnostic performance of circulating microRNAs in detecting the presence of germ cell cancer in patients with small testicular mass or retroperitoneal post-chemotherapy residual mass and suitable for testis sparing surgery and retroperitoneal lymph node dissection, respectively.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-26.
Trial Details
NCT Number NCT06620016
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Testicular Cancer
Enrollment 60 participants
Start Date 2024-10-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-21